SYK, ISRG, DXCM: Which “Strong Buy” Healthcare Stock Is the Best Bet?
TipRanks · 1d ago
Peering Into Stryker's Recent Short Interest
Stryker's short percent of float has risen 7.55% since its last report. The company has 4.11 million shares sold short, which is 1.14% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 1d ago
My Dividend Stock Portfolio: New June Dividend Record - 101 Holdings With 22 Buys
My Dividend Stock Portfolio hit a new record of 101 Holdings With 22 Buys in June. In June, Stefan Redlich added $131 to his yearly dividend income of $1.7 million. He is aiming to increase dividend income by at least $100 each month. Main portfolio picks included Ares Capital, Hercules Capital, and Goldman Sachs BDC.
Seeking Alpha · 1d ago
LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Seeking Alpha · 2d ago
Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval
NASDAQ · 3d ago
Validea Detailed Fundamental Analysis - SYK
NASDAQ · 3d ago
Stryker Corporation (NYSE:SYK) On An Uptrend: Could Fundamentals Be Driving The Stock?
Stryker's (NYSE:SYK) ROE is 18% higher than the industry average. The company's net income growth has been flat over the past five years. Stryker has a high return on equity of 18%, but its earnings growth is lower than the average for its industry. The ROE of 18% is based on the company's earnings growth over the last year. It measures how well a company is able to reinvest its profits in its market. StRYK's stock has risen 3.8% since last week.
Simply Wall St · 3d ago
Weekly Report: what happened at SYK last week (0715-0719)?
Weekly Report · 3d ago
Johnson & Johnson’s Q2 Profit Beats Forecasts on Drug Sales
NASDAQ · 07/17 23:49
Catalent (CTLT) Expands Its Facility Capabilities in Germany
NASDAQ · 07/16 16:28
Stryker (SYK) Completes Artelon's Acquisition to Boost Business
NASDAQ · 07/16 16:16
DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock?
NASDAQ · 07/16 16:14
Stryker’s Q2 2024 Earnings: What to Expect
Stryker Corporation (SYK) is expected to announce its fiscal second-quarter earnings for 2024 after the market closes on Tuesday, Jul. 30. The medical devices and equipment maker provides specialty surgical and medical products and services. SYK stock has underperformed the S&P 500's 18.5% gains on a YTD basis.
Barchart · 07/16 11:27
Patterson Companies (PDCO) Aims to Streamline Patient Experience
NASDAQ · 07/15 17:44
Stryker Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 07/15 17:12
Stryker Price Target Raised to $350.00/Share From $345.00 by Morgan Stanley
Dow Jones · 07/15 17:12
Stryker Is Maintained at Buy by BTIG
Dow Jones · 07/15 17:02
Stryker Price Target Raised to $372.00/Share From $369.00 by BTIG
Dow Jones · 07/15 17:02
Morgan Stanley Maintains Equal-Weight on Stryker, Raises Price Target to $350
Benzinga · 07/15 17:01
Webull provides a variety of real-time SYK stock news. You can receive the latest news about Stryker Corp through multiple platforms. This information may help you make smarter investment decisions.
About SYK
Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It also specializes in soft tissue fixation products.